For oncologists navigating the rapidly evolving landscape of renal cell carcinoma (RCC), the data presented at the 2026 ASCO ...

LITESPARK-011 demonstrated improved progression-free survival with the combination of belzutifan plus lenvatinib vs ...

The CAIX targeting radiotracer 68 Ga-C1 was developed and validated through in vitro assays. Initially, the investigators ...

The US Food and Drug Administration (FDA) has approved belzutifan (Welireg) for adults with advanced renal cell carcinoma following progression on a PD-1/L1 inhibitor and a vascular endothelial growth ...

Merck (NYSE:MRK) reported new Phase 3 data for belzutifan based WELIREG regimens in renal cell carcinoma, showing meaningful ...

The combination of belzutifan plus lenvatinib significantly improved outcomes for patients with clear cell renal cell carcinoma who progressed following immunotherapy compared with cabozantinib ...

Many medicines are available to treat kidney cancer. If one treatment doesn’t help or stops working, your health care provider may recommend another option. If you or a loved one has kidney cancer and ...

(HealthDay News) — For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, ...

The findings suggest that integrating comprehensive genomic profiling into clinical practice could assist physicians in tailoring treatments for mccRCC on the basis of individual patients' genetic ...

The lead singer of the band 3 Doors Down shared Wednesday that he has stage 4 kidney cancer that has spread to his lung. In an Instagram video, Brad Arnold said he had been feeling sick for a few ...